European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

AbbVie Overseas Sàrl, Luxembourg✝︎

Watch
AbbVie Overseas Sàrl

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Create Dossier
AbbVie Overseas Sàrl

The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .

Add to dossier (if available):

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Risk report
AbbVie Overseas Sàrl
Risk Level Evaluation Source
Sanctioned (?)
Anti-trust proceedings (?)

Name

AbbVie Overseas Sàrl
WCA Pharmaceuticals Overseas Sàrl

Identification

Rcsp
RCS B167837
Lei
549300FSFD23WP1OLS35
EUID
LURCSL.B167837

Address

Luxembourg, Luxembourg

Corporate purpose

64.20
Activities of holding companies

History

Network

Loading network

Legal Structure

Last legal representatives Legal form information Premium
Premium
5Managing Director
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans

JOBS AT NORTH DATA

  • Modern Java Developer

Publications

31 Mar 2026
Modification - Filing of a decision for publication, with no impact on the data registered with the RCS
25 Aug 2021
Ter­mi­na­tion: 16/08/2021
28 Jun 2021
Annual report for the year ending 31/12/2020 · Balance sheet for 31/12/2020
17 Jun 2021 also 02/09/2019
Merger / demerger /professional property and staff transfer project
16 Jun 2021
Patent: Substituted Pyrrolidines and Their USE in the Treatment of Cystic Fiibrosis
7 May 2021 also 05/05/2021, 09/10/2019, 05/03/2019, 08/12/2017, 04/11/2016, 04/11/2016, 04/11/2016, 13/01/2015
Consolidated accounts
23 Feb 2021
Annual report for the year ending 31/12/2019 · Balance sheet for 31/12/2019
5 Aug 2020
Patent: Substituted pyrazolo[3,4-b]pyridine-6-carboxylic acids and their use
1 Apr 2020
Patent: Substituted benzotetrahydropyrans and their use
2 Mar 2020
Managing Director: Kim Marie Stawski, Elzbieta Anna Szlaga · Manager: Elzbieta Anna Szlaga · No longer Managing Director: Jin Hee Kim, Sophie Morlet · No longer Manager: Sophie Morlet
17 Feb 2020 also 04/10/2012, 06/06/2012
Articles of association
18 Dec 2019
Patent: Substituted Tricyclines and Method of Use
16 Dec 2019
Shareholder: AbbVie International Sàrl · Capital: $4.39B
2 Dec 2019
Managing Director: Sophie Morlet · Manager: Sophie Morlet · No longer Managing Director: Nadine Saffer · No longer Manager: Nadine Saffer
9 Oct 2019
Annual report for the year ending 31/12/2018 · Balance sheet for 31/12/2018
12 Aug 2019
Non-statutory modification of the agents
24 Jul 2019
Managing Director: Jin Hee Kim · No longer Managing Director: Richard Ch. Plendl
3 Apr 2019
Patent: Substituted Pyrrolidines and Their USE
27 Mar 2019
Managing Director: Robert A. Michael
4 Mar 2019
Annual report for the year ending 31/12/2017 · Balance sheet for 31/12/2017
8 May 2018
Annual report for the year ending 31/12/2016 · Balance sheet for 31/12/2016
Year 2017 in Dpmap
11 patent filings: Heteroarylsubstituierte Pyridine und Verfahren zur Verwendung …
26 Jul 2017
Manager: Nadine Saffer
20 Jul 2017
Statutory/non-statutory modification without registration
6 Jul 2017
Manager: Nadine Saffer
27 Jan 2017 also 04/11/2016, 04/11/2016, 23/07/2015
Annual accounts (eCDF)
14 Dec 2016
Managing Director: Luca Gallinelli, Tony Whiteman · No longer Managing Director: Richard Brekelmans, Franciscus Welman
7 Oct 2016
Patent: Substituted Pyrazolo[3,4-B]Pyridin-6-Carboxylic Acids and Their USE
1 Jul 2016
Managing Director: Franciscus Welman · No longer Managing Director (1)
19 May 2016
Managing Director: Nadine Saffer · No longer Managing Director: Sophie Morlet
14 Apr 2016
Managing Director (1) · No longer Managing Director (1)
28 Oct 2015
Patent: Substituted chromanes and process for use
9 Sept 2015
Managing Director: Richard Ch. Plendl · No longer Managing Director (1)
14 Feb 2013 also 03/01/2013, 13/08/2012, 07/08/2012, 11/07/2012, 03/05/2012
Modification
28 Nov 2012
Modification filing of previously filed documents (correction or additional)
There are no publications matching your search.

Mentions

10 Nov 2025 in Ler
Direct parent
10 Nov 2025 in Ler
Ultimate parent
13 Jul 2021 in Wzfma also 09/07/2021, 26/01/2016, 21/01/2016
Shareholding: AbbVie GmbH
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Printing is only available to North Data premium service subscribers.